Business Description
Keymed Biosciences Inc
ISIN : KYG5252B1023
Compare
Compare
Traded in other countries / regions
02162.Hong Kong64Z.Germany IPO Date
2021-07-08Description
Keymed Biosciences Inc is a biotechnology company with multiple clinical-stage assets. The company is focused on the in-house discovery and development of biological therapies that address large underserved medical needs in the autoimmune and oncology therapeutic areas. Its clinical-stage drug candidates include CM310, CM326, CM313, and CM336 among others. The company is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment. Geographically, it generates a majority of its revenue from overseas markets and the rest from Mainland China.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.56 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.28 | |||||
| Debt-to-EBITDA | -1.14 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 5.26 | |||||
| Beneish M-Score | 0.51 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 31 | |||||
| 3-Year EPS without NRI Growth Rate | 25.2 | |||||
| 3-Year FCF Growth Rate | -67.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 72.85 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.08 | |||||
| 9-Day RSI | 39.25 | |||||
| 14-Day RSI | 42.19 | |||||
| 6-1 Month Momentum % | 35.17 | |||||
| 12-1 Month Momentum % | -22.09 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.98 | |||||
| Quick Ratio | 4.83 | |||||
| Cash Ratio | 4.6 | |||||
| Days Inventory | 1045.21 | |||||
| Days Sales Outstanding | 51.67 | |||||
| Days Payable | 443.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.7 | |||||
| Shareholder Yield % | -3.02 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.39 | |||||
| Operating Margin % | -972.56 | |||||
| Net Margin % | -913.17 | |||||
| FCF Margin % | -1106.04 | |||||
| ROE % | -24.71 | |||||
| ROA % | -18.92 | |||||
| ROIC % | -68.92 | |||||
| ROC (Joel Greenblatt) % | -77.14 | |||||
| ROCE % | -20.18 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 113.47 | |||||
| PB Ratio | 3.75 | |||||
| Price-to-Tangible-Book | 3.76 | |||||
| EV-to-EBIT | -11.36 | |||||
| EV-to-EBITDA | -12.96 | |||||
| EV-to-Revenue | 100.24 | |||||
| EV-to-FCF | -9.13 | |||||
| Price-to-Net-Current-Asset-Value | 6.1 | |||||
| Price-to-Net-Cash | 7.02 | |||||
| Earnings Yield (Greenblatt) % | -8.8 | |||||
| FCF Yield % | -9.19 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Keymed Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 88.368 | ||
| EPS (TTM) (HK$) | -3.084 | ||
| Beta | 0.63 | ||
| Volatility % | 49.4 | ||
| 14-Day RSI | 42.19 | ||
| 14-Day ATR (HK$) | 2.388826 | ||
| 20-Day SMA (HK$) | 40.9975 | ||
| 12-1 Month Momentum % | -22.09 | ||
| 52-Week Range (HK$) | 26.6 - 57 | ||
| Shares Outstanding (Mil) | 277.39 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Keymed Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Keymed Biosciences Inc Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Keymed Biosciences Inc Frequently Asked Questions
What is Keymed Biosciences Inc(HKSE:02162)'s stock price today?
The current price of HKSE:02162 is HK$38.35. The 52 week high of HKSE:02162 is HK$57.00 and 52 week low is HK$26.60.
When is next earnings date of Keymed Biosciences Inc(HKSE:02162)?
The next earnings date of Keymed Biosciences Inc(HKSE:02162) is .
Does Keymed Biosciences Inc(HKSE:02162) pay dividends? If so, how much?
Keymed Biosciences Inc(HKSE:02162) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers